H-beta-(2-Thiazolyl)-DL-Ala-OH

H-beta-(2-Thiazolyl)-DL-Ala-OH is a thiazole-substituted alanine derivative in which the beta position bears a 2-thiazolyl heteroaryl group while the amino acid backbone retains the free carboxylic acid and an amino functionality consistent with an alanine stereochemical framework. The molecule is supplied as a DL (racemic) mixture, so both enantiomers of the chiral center at the alpha carbon are present, enabling stereochemical comparisons in peptide and heterocycle chemistry. The 2-thiazolyl ring contributes heteroatom-rich aromatic character and can participate in electrophilic aromatic substitution, metal coordination, and heteroaryl reactivity under standard organic synthesis conditions. The combination of an amino acid handle with a functional heteroaryl side chain makes the compound suitable as a chiral building block precursor, a protected amino acid intermediate, or a functionalized amino acid scaffold for downstream peptide and medicinal chemistry workflows.

1. Peptide Synthesis

H-beta-(2-Thiazolyl)-DL-Ala-OH is applied in peptide building block preparation where the amino acid backbone supports conventional peptide coupling after appropriate N-protection and activation of the carboxyl group. The side-chain 2-thiazolyl substituent can be retained through amide bond formation, allowing incorporation of a heteroaryl-bearing alanine residue into peptide sequences for structure-activity relationship studies and peptidomimetic design. Racemic availability enables rapid generation of diastereomer- and enantiomer-mixed analog panels, which can be useful when screening peptide-like scaffolds for binding or stability trends. The resulting thiazolyl-containing peptides can serve as intermediates for further functional group transformations on the heteroaryl ring.

2. Amino Acid Derivatization

H-beta-(2-Thiazolyl)-DL-Ala-OH functions as a substrate for amino acid derivatization strategies that target the carboxylic acid and amino group while preserving the 2-thiazolyl moiety for subsequent heteroaryl chemistry. The free acid can be converted into activated esters or amide-forming derivatives, supporting C-terminal modification, conjugation handle installation, or protected amino acid synthesis for controlled peptide assembly. The thiazole ring can undergo metal-catalyzed cross-coupling, electrophilic substitution, or oxidative transformations depending on the selected conditions, enabling downstream generation of substituted thiazole analogs from a common amino acid precursor. The DL stereochemical nature supports parallel synthesis of stereochemical variants for mapping side-chain effects on molecular recognition.

3. Chemical Biology Probes

H-beta-(2-Thiazolyl)-DL-Ala-OH is suitable for chemical biology workflows that require amino acid-derived probes bearing a heteroaryl reporter or recognition element. The 2-thiazolyl side chain provides a defined aromatic heterocycle that can be used for affinity tuning, labeling strategies, or as a scaffold for further functionalization prior to bioconjugation. The amino acid backbone enables conversion into N-protected derivatives for incorporation into peptide-based probes, or into activated forms for attachment to carrier proteins and biomolecule scaffolds. Downstream probe construction can leverage thiazole reactivity to introduce additional substituents that modulate hydrophobicity, binding interactions, or physicochemical properties relevant to assay development.

4. Peptidomimetics And SAR

H-beta-(2-Thiazolyl)-DL-Ala-OH supports peptidomimetic construction and SAR studies by providing a heteroaryl-bearing alanine motif that can be embedded into constrained analogs or used as a fragment for iterative scaffold refinement. The defined alpha-amino acid geometry and the beta-(2-thiazolyl) side chain enable systematic exploration of how heteroaryl electronics and sterics influence target engagement patterns in medicinal chemistry programs. Racemic input can accelerate early-stage analog generation, while later stereochemical resolution or asymmetric synthesis can be applied when enantiomer-specific effects become evident. The resulting thiazolyl-containing intermediates can be further elaborated into non-natural amino acid derivatives, cyclized motifs, or heteroaryl-substituted pharmacophore fragments.

5. Pharmaceutical Intermediate Preparation

H-beta-(2-Thiazolyl)-DL-Ala-OH is used in pharmaceutical intermediate preparation where amino acid functional groups serve as handles for controlled protection, activation, and late-stage diversification. The carboxylic acid and amino functionality allow conversion into N-protected amino acid derivatives and C-terminal activated intermediates compatible with peptide coupling chemistry and medicinal chemistry derivatization. The 2-thiazolyl heterocycle can be carried through intermediate steps and then selectively modified to generate substituted heteroaryl analogs used in lead optimization. Industrial fine chemical synthesis can employ this amino acid-based intermediate to streamline routes toward heteroaryl-containing building blocks that are compatible with both solid-phase and solution-phase assembly strategies.

1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L